RxDoctor Payments Data

Brian Wood, MD

Family Medicine · Auburn, ALNPI 1558473074

Payments from drug & device makers

$2,146in general payments, 2019–2025

Across 40 payments — averaging $53.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$1K
  • Boston Scientific$298
  • AbbVie$122
  • Abbott$114
  • Terumo Medical Corporation$106
  • Otsuka America Pharmaceutical, Inc.$71
  • plus $296 from 12 others

What the payments were for

  • Travel & lodging$1,13853%
  • Food & beverage$1,00747%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,146 in reported general payments places this provider in the 70th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$81,718
Medicare patients
250
Services billed
1,356

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$111,321
MounjaroTirzepatide65$91,348
EliquisApixaban38$43,637
JanuviaSitagliptin Phosphate23$24,618
XareltoRivaroxaban18$18,254
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,357
VascepaIcosapent Ethyl12$8,944
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$5,807
Atorvastatin Calcium498$5,769
Valsartan170$5,721
Levothyroxine Sodium366$4,987
Esomeprazole Magnesium65$4,384
Losartan Potassium275$3,974
Omega-3 Acid Ethyl Esters15$3,716
Mirtazapine128$3,493

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$31$111,32172 claims
Lilly USA, LLCMounjaro$13$91,34865 claims
PfizerEliquis$50$43,63738 claims
AbbVieSynthroid$122$3,46743 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Auburn

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →